Shares of Revvity Inc. (NYSE:RVTY – Get Free Report) have been assigned an average recommendation of “Hold” from the fourteen research firms that are covering the stock, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, eight have given a hold recommendation and five have assigned a buy recommendation to the company. The average 12-month price objective among brokerages that have issued ratings on the stock in the last year is $113.6667.
RVTY has been the subject of several recent research reports. Barclays upped their target price on shares of Revvity from $115.00 to $118.00 and gave the company an “overweight” rating in a research report on Tuesday, February 3rd. JPMorgan Chase & Co. lifted their price objective on Revvity from $100.00 to $105.00 and gave the stock a “neutral” rating in a research note on Tuesday, February 3rd. The Goldman Sachs Group initiated coverage on Revvity in a report on Tuesday, December 9th. They issued a “neutral” rating and a $105.00 price objective for the company. Wall Street Zen raised Revvity from a “hold” rating to a “buy” rating in a research note on Saturday, February 28th. Finally, Evercore raised their target price on Revvity from $112.00 to $118.00 and gave the stock an “outperform” rating in a report on Tuesday, February 3rd.
Check Out Our Latest Stock Report on RVTY
Institutional Inflows and Outflows
Revvity Stock Up 0.1%
Shares of NYSE:RVTY opened at $85.88 on Monday. Revvity has a one year low of $81.36 and a one year high of $118.30. The company has a 50 day moving average of $100.56 and a 200-day moving average of $96.52. The company has a debt-to-equity ratio of 0.36, a current ratio of 1.68 and a quick ratio of 1.40. The stock has a market cap of $9.60 billion, a price-to-earnings ratio of 41.29, a P/E/G ratio of 1.83 and a beta of 1.10.
Revvity (NYSE:RVTY – Get Free Report) last announced its quarterly earnings data on Monday, February 2nd. The company reported $1.70 earnings per share for the quarter, beating the consensus estimate of $1.55 by $0.15. Revvity had a net margin of 8.45% and a return on equity of 7.92%. The business had revenue of $772.06 million for the quarter, compared to analyst estimates of $759.81 million. During the same period in the prior year, the business posted $1.42 earnings per share. Revvity’s revenue was up 5.9% compared to the same quarter last year. Revvity has set its FY 2026 guidance at 5.350-5.450 EPS. On average, sell-side analysts forecast that Revvity will post 4.94 earnings per share for the current year.
Revvity Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Friday, May 8th. Investors of record on Friday, April 17th will be given a $0.07 dividend. This represents a $0.28 dividend on an annualized basis and a dividend yield of 0.3%. The ex-dividend date is Friday, April 17th. Revvity’s dividend payout ratio (DPR) is currently 13.46%.
About Revvity
Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.
Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.
Recommended Stories
Receive News & Ratings for Revvity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Revvity and related companies with MarketBeat.com's FREE daily email newsletter.
